Medical device maker Boston Scientific Corp. plans to pay more than $200 million to buy the remaining stake in a device company called Cryterion Medical, which owns an invention that uses a burst ...

Boston Scientific is acquiring Cryterion Medical, a company the medical device giant has invested in since its launch in 2016, by buying up the remaining 65% stake for $202 million upfront as ...

Boston Scientific Corp. (BSX) on Thursday said it agreed to buy the roughly 65% of Cryterion Medical Inc. it doesn’t already own for $202 million in cash. Cryterion is developing a single-shot ...

Cryterion Medical is developing a treatment for atrial fibrillation, or irregular heartbeat. Boston Scientific has been an investor in the company since it was launched in 2016. Boston Scientific ...

Boston Scientific CorporationBSX recently announced the acquisition of Cryterion Medical, Inc. - a privately-held developer of a single-shot cryoablation platform for the treatment of atrial ...

Boston Scientific Corp. has inked an agreement to acquire the rest of Cryterion Medical Inc. it does not own for $202 million in up-front cash. The attraction of Cryterion, of Carlsbad, Calif., is the ...